Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis? ; volume:3 ; number:1 ; day:25 ; month:1 ; year:2017 ; pages:1-20 ; date:12.2017
npj Parkinson's Disease ; 3, Heft 1 (25.1.2017), 1-20, 12.2017
- Urheber
-
Qamar, MA
Sauerbier, A.
Politis, M.
Carr, H.
Loehrer, P A.
Chaudhuri, K Ray
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-016-0006-9
- URN
-
urn:nbn:de:101:1-2503040845251.180765431023
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Qamar, MA
- Sauerbier, A.
- Politis, M.
- Carr, H.
- Loehrer, P A.
- Chaudhuri, K Ray
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s disease
Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
Gastrodin protects dopaminergic neurons via insulin-like pathway in a Parkinson’s disease model
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patients
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways